<h1>Government imposes immediate 100% import tax on drugs and other goods, sparking market losses and legal challenges</h1> A national executive announced immediate tariff measures, including a 100% import tax on pharmaceutical drugs effective October 1, invoking national security and other justifications; the proclamation also targets furniture, cabinetry, heavy trucks and parts. Markets reacted with regional equity declines and sector-specific losses for major pharmaceutical firms, while concerns over prolonged tariff negotiations heightened trade tensions with key trading partners. Legally, the measures raise issues under domestic customs law and potential challenges under international trade agreements (including dispute settlement claims), may prompt retaliatory tariffs, and could affect regulatory and monetary policy expectations tied to economic and market stability.